Zynex (NASDAQ:ZYXI) Releases Q3 2024 Earnings Guidance

Zynex (NASDAQ:ZYXI) updated its third quarter 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.050- for the period, compared to the consensus estimate of 0.160. The company issued revenue guidance of $50.0 million-, compared to the consensus revenue estimate of $60.2 million. Zynex also updated its FY 2024 guidance to 0.200- EPS.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. HC Wainwright restated a buy rating and issued a $21.00 price target on shares of Zynex in a research note on Wednesday, May 1st. Royal Bank of Canada restated an outperform rating and issued a $15.00 price target on shares of Zynex in a research note on Friday, June 14th.

Zynex Stock Performance

Zynex stock traded up $0.11 during mid-day trading on Thursday, reaching $10.19. 106,410 shares of the stock traded hands, compared to its average volume of 189,196. The stock has a market capitalization of $323.74 million, a PE ratio of 44.30 and a beta of 0.53. The company has a debt-to-equity ratio of 1.76, a current ratio of 3.58 and a quick ratio of 2.87. Zynex has a 12-month low of $6.88 and a 12-month high of $13.77. The business’s 50-day moving average is $9.59 and its 200-day moving average is $11.07.

Zynex Company Profile

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.